SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy

Clinical trial NCT07096999 · RECRUITING

Trial details

NCT number: NCT07096999
Sponsor: University of Michigan Rogel Cancer Center
Status: RECRUITING
Study type: OBSERVATIONAL

Metastatic Castration-Resistant Prostate Carcinoma

Start date: 2025-01-23
Primary completion: 2031-01-23
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.